Results of a phase I dose escalation study in the treatment of inoperable non-small cell lung cancer

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/s0360-3016(03)01361-0 ◽

2003 ◽

Vol 57 (2) ◽

pp. S417-S418 ◽

Author(s):

K.E Rosenzweig ◽

E Yorke ◽

A Jackson ◽

R Nayak ◽

V.W Rusch ◽

...

Keyword(s):

Lung Cancer ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Dose Escalation ◽

Small Cell Lung ◽

Dose Escalation Study

Download Full-text

Phase I dose escalation study of pemetrexed and concurrent thoracic radiation in elderly patients with non-squamous non–small-cell lung cancer

Journal of Radiation Research ◽

10.1093/jrr/rry058 ◽

2018 ◽

Vol 60 (2) ◽

pp. 228-233

Author(s):

Kyoichi Kaira ◽

Akihiro Ono ◽

Yosuke Kamide ◽

Noriaki Sunaga ◽

Yasuhiko Koga ◽

...

Keyword(s):

Lung Cancer ◽

Elderly Patients ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Dose Escalation ◽

Small Cell Lung ◽

Dose Escalation Study ◽

Thoracic Radiation

Download Full-text

A Phase I Dose-Escalation Study of Veliparib Combined with Carboplatin and Etoposide in Patients with Extensive-Stage Small Cell Lung Cancer and Other Solid Tumors

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-18-2014 ◽

2018 ◽

Vol 25 (2) ◽

pp. 496-505 ◽

Author(s):

Florence Atrafi ◽

Harry J.M. Groen ◽

Lauren A. Byers ◽

Elena Garralda ◽

Martijn P. Lolkema ◽

...

Keyword(s):

Lung Cancer ◽

Phase I ◽

Small Cell Lung Cancer ◽

Solid Tumors ◽

Cell Lung Cancer ◽

Dose Escalation ◽

Small Cell Lung ◽

Dose Escalation Study ◽

Extensive Stage

Download Full-text

Raltitrexed (‘Tomudex’) and cisplatin in metastatic non-small cell lung cancer (NSCLC): Preliminary results of a Phase I dose-escalation study

European Journal of Cancer ◽

10.1016/s0959-8049(99)81422-1 ◽

1999 ◽

Vol 35 ◽

pp. S253 ◽

Author(s):

C. Manegold ◽

E. Buchholz ◽

R. Kloeppel ◽

C. Kreisel ◽

M. Smith

Keyword(s):

Lung Cancer ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Dose Escalation ◽

Small Cell Lung ◽

Dose Escalation Study ◽

Preliminary Results

Download Full-text

Ensartinib (X-396), a second-generation ALK TKI, in Chinese ALK-positive non-small cell lung cancer: A phase I, dose-escalation study.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.e21122 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. e21122-e21122 ◽

Author(s):

Wenfeng Fang ◽

Yuxiang Ma ◽

Jianjin Huang ◽

Yang Zhang ◽

Benyan Zou ◽

...

Keyword(s):

Lung Cancer ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Dose Escalation ◽

Second Generation ◽

Small Cell Lung ◽

Dose Escalation Study ◽

Download Full-text

Phase I dose escalation study of amrubicin plus paclitaxel in previously treated advanced non-small cell lung cancer

International Journal of Clinical Oncology ◽

10.1007/s10147-015-0883-7 ◽

2015 ◽

Vol 21 (2) ◽

pp. 240-247 ◽

Author(s):

Kyoichi Kaira ◽

Noriaki Sunaga ◽

Hisao Imai ◽

Yosuke Kamide ◽

Yasuhiko Koga ◽

...

Keyword(s):

Lung Cancer ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Dose Escalation ◽

Small Cell Lung ◽

Dose Escalation Study ◽

Previously Treated

Download Full-text

9163 Phase I dose-escalation study of vorinostat in combination with gemcitabine and cisplatinum in patients with advanced non-small-cell lung cancer (NSCLC)

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(09)71876-2 ◽

2009 ◽

Vol 7 (2) ◽

pp. 554

Author(s):

L. Teixeira ◽

R. Descourt ◽

D. Moro-Sibilot ◽

J.L. Misset ◽

E. Gachard ◽

...

Keyword(s):

Lung Cancer ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Dose Escalation ◽

Small Cell Lung ◽

Dose Escalation Study

Download Full-text

A Phase I/II Radiation Dose Escalation Study With Concurrent Chemotherapy for Patients With Inoperable Stages I to III Non-Small-Cell Lung Cancer: Phase I Results of RTOG 0117

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2009.04.029 ◽

2010 ◽

Vol 77 (2) ◽

pp. 367-372 ◽

Author(s):

Jeffrey D. Bradley ◽

Jennifer Moughan ◽

Mary V. Graham ◽

Roger Byhardt ◽

Ramaswamy Govindan ◽

...

Keyword(s):

Lung Cancer ◽

Radiation Dose ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Dose Escalation ◽

Concurrent Chemotherapy ◽

Small Cell Lung ◽

Dose Escalation Study

Download Full-text

Cisplatin + gemcitabine in non-small cell lung cancer (NSCLC). A phase I dose escalation study

Lung Cancer ◽

10.1016/0169-5002(94)94206-4 ◽

1994 ◽

Vol 11 ◽

pp. 114 ◽

Keyword(s):

Lung Cancer ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Dose Escalation ◽

Small Cell Lung ◽

Dose Escalation Study

Download Full-text

A phase I dose escalation study of cisplatin, pemetrexed and radiotherapy for inoperable stage III non-small cell lung cancer

http://isrctn.org/> ◽

10.1186/isrctn91946477 ◽

2013 ◽

Author(s):

V F M Surmont

Keyword(s):

Lung Cancer ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Dose Escalation ◽

Stage Iii ◽

Small Cell Lung ◽

Dose Escalation Study

Download Full-text

Sunitinib in combination with gemcitabine plus cisplatin for advanced non-small cell lung cancer: A phase I dose-escalation study

Lung Cancer ◽

10.1016/j.lungcan.2010.01.016 ◽

2010 ◽

Vol 70 (2) ◽

pp. 180-187 ◽

Author(s):

Martin Reck ◽

Norbert Frickhofen ◽

Susana Cedres ◽

Ulrich Gatzemeier ◽

David Heigener ◽

...

Keyword(s):

Lung Cancer ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Dose Escalation ◽

Small Cell Lung ◽

Dose Escalation Study

Download Full-text